Mutual Exclusivity of Mutations Across Different Cancer Types - A Molecular Network Perspective
summary
Examines mutually exclusive mutation patterns across various cancer types using molecular network analysis, focusing on how network relationships explain or reveal exclusivity of mutations. Describes computational approaches that integrate mutation data with molecular interaction networks to identify and interpret mutually exclusive alterations.
AI-written summary · about
chapters (17)
- 0:00Intro
- 0:40Cancer drivers, passengers, supporting actors, witnesses
- 1:22Cancer-driving pathways: examples of BRCA-mutated genes in their pathway context
- 2:16Mutual exclusivity of cancer drivers
- 4:09Mutually exclusive pairs often share pathways
- 5:24Introducing a classification of mutual exclusivity
- 7:01Mutual exclusivity classes in the Pan-Cancer context
- 11:58Finding Pan-Cancer dysregulated pathways: ME Module Cover Approach
- 14:15Does putting together ACROSS ME and
- 18:26Beyond cancer drivers
- 20:51FBXW7: tumor suppressor but possible passenger
- 21:31What is the train TTN is riding on?
- 21:54TTN carries the APOBEC signature in BRCA and the Pol ε signature in UCEC
- 26:00Can APOBEC cause TP53 mutations? Burns et al.
- 27:27True for all TP53 mutations in BRCA?
- 28:34TTN and TP53 share exclusivity partners
- 28:46Genes mutually exclusive with TTN are predictors of better survival
